Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2014 2
2016 1
2017 1
2020 6
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
Simoni N, Micera R, Paiella S, Guariglia S, Zivelonghi E, Malleo G, Rossi G, Addari L, Giuliani T, Pollini T, Cavedon C, Salvia R, Milella M, Bassi C, Mazzarotto R. Simoni N, et al. Among authors: micera r. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e31-e38. doi: 10.1016/j.clon.2020.06.019. Epub 2020 Jul 15. Clin Oncol (R Coll Radiol). 2021. PMID: 32682686
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Paiella S, Malleo G, Simoni N, Micera R, Guariglia S, Cavedon C, Marchegiani G, Esposito A, Landoni L, Casetti L, Tuveri M, Milella M, Secchettin E, Manzini G, Bovo C, De Pastena M, Fontana M, Salvia R, Mazzarotto R, Bassi C. Paiella S, et al. Among authors: micera r. BMC Cancer. 2021 Feb 16;21(1):165. doi: 10.1186/s12885-021-07877-7. BMC Cancer. 2021. PMID: 33593311 Free PMC article.
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer.
Simoni N, Pavarana M, Micera R, Weindelmayer J, Mengardo V, Rossi G, Cenzi D, Tomezzoli A, Del Bianco P, Giacopuzzi S, De Manzoni G, Mazzarotto R. Simoni N, et al. Among authors: micera r. Cancers (Basel). 2020 Dec 3;12(12):3614. doi: 10.3390/cancers12123614. Cancers (Basel). 2020. PMID: 33287147 Free PMC article.
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy.
La Mendola R, Bencivenga M, Torroni L, Alberti L, Sacco M, Casella F, Ridolfi C, Simoni N, Micera R, Pavarana M, Verlato G, Giacopuzzi S. La Mendola R, et al. Among authors: micera r. Ann Surg Oncol. 2021 Jun;28(6):3034-3043. doi: 10.1245/s10434-020-09219-6. Epub 2020 Oct 19. Ann Surg Oncol. 2021. PMID: 33078313 Free PMC article.
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar.
Mazzarotto R, Simoni N, Guariglia S, Rossi G, Micera R, De Robertis R, Pierelli A, Zivelonghi E, Malleo G, Paiella S, Salvia R, Cavedon C, Milella M, Bassi C. Mazzarotto R, et al. Among authors: micera r. Front Oncol. 2020 Dec 17;10:600940. doi: 10.3389/fonc.2020.600940. eCollection 2020. Front Oncol. 2020. PMID: 33392093 Free PMC article.
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy.
Simoni N, Rossi G, Benetti G, Zuffante M, Micera R, Pavarana M, Guariglia S, Zivelonghi E, Mengardo V, Weindelmayer J, Giacopuzzi S, de Manzoni G, Cavedon C, Mazzarotto R. Simoni N, et al. Among authors: micera r. Front Oncol. 2020 Nov 27;10:599907. doi: 10.3389/fonc.2020.599907. eCollection 2020. Front Oncol. 2020. PMID: 33330097 Free PMC article.
13 results